Sector Alpha Week of 2026-07-31
Sector Alpha — machine-written from the numbers · Data as of 2026-07-31

DCM Shriram Ltd

DCMSHRIRAM
Sugar

DCM Shriram Ltd's earnings have outrun its stock. EPS grew +41.2% in a year against a −24.8% price move.

The sharpest disagreement: annual EPS moved +41.2% against a −24.8% price move — the market has not yet caught up with the delivery.

The price is in a downtrend (8 weeks in) while the P/E sits at the 47th percentile of its own 10-year range. Underneath, the last four quarters read improving — profit +507.9% year on year, and 165% of the last 3 years' profit arrived as cash. What settles it: whether the price catches up with earnings that have already moved.

Stage
Mixed
fundamental trajectory, 12 quarters
Price
₹1,034
−24.8% 1Y
P/E
11.8×
47th pctile
of its own 10-year range
Revenue (Jun 26)
₹3,564 Cr
+9.3% YoY
Profit (Jun 26)
₹693 Cr
+507.9% YoY
Operating margin
9.0%
flat YoY
ROCE
12%
FY26
ROIC
10.5%
vs WACC 12.0% → −1.5 pp
Cash conversion
165%
of profit, last 3 FY
01 · Price story

Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.

DCM Shriram Ltd trades at ₹1,034, in a downtrend and 8 weeks into that stage. That is −7.1% against its own 200-day average. It sits at 15% of a 52-week range of ₹990 to ₹1,281. On relative strength it is currently behind the NIFTY 500 on a trailing-13-week view (13 weeks and counting).

Today the stock is in a downtrend — week 8 of stage 4, confirmed. At ₹1,034 it trades −7.1% versus its 200-day average and sits at 15% of its 52-week range (₹990–₹1,281).

Jul 26: ₹1,034 Weekly closing price (₹) with 50- and 200-day averages; shaded bands mark the price stage (grey base, green advance, amber top, red decline). 3-year window.
−7.1% versus the 200-day line, week 8 of stage 4
Price50-day avg200-day avg
S2S2S2S4S4₹1,453₹1,289₹1,125₹961₹797₹1,034₹1,113Jul 23May 24Feb 25Nov 25Jul 26
S2S2S2S4S4₹1,453₹1,289₹1,125₹961₹797₹1,034₹1,113Jul 23Feb 25Jul 26
Beating or trailing, week by week since 2016 Each cell is one week from 2016 to now (548 weeks): the stock's trailing 13-week return minus the NIFTY 500's, green ahead / red behind (±25% ramp). Grey cells are the 13-week warm-up or weeks where the NIFTY 500 reading is not held.
trailing 13-week return vs the NIFTY 500
Mar 16Jul 26

Against the market, two honest reads. Cumulative: over the last 10.4 years the stock moved +740% while the NIFTY 500 moved +276% — ahead of the index over the full window. Recent form: on a trailing-13-week view the stock is currently behind (13 weeks and counting; last ahead the week of 2026-06-04) — the ribbon below is that same metric, week by week.

What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.

02 · Valuation

Valuation P/E is the price of ₹1 of annual profit: how many rupees the market pays for each rupee the company earns in a year.

DCM Shriram Ltd trades at 11.8× P/E, mid-range by its own standards (47th percentile). Its long-run median P/E is 12.7×, measured across 10.4 years of weekly readings. This places the multiple against the stock’s own record, and says nothing about what the business is worth.

Today's P/E of 11.8× is mid-range by its own standards (47th percentile), against a long-run median of 12.7× measured over 10.4 years of weekly readings. This is a comparison against the stock's own history — not a claim about what it is worth.

P/E 11.8× vs a 12.7× long-run median P/E, weekly (left axis); earnings per share, trailing twelve months, weekly (right axis). 10.4-year window; loss-period spikes above 36× shown pinned at the top. The eps (ttm) bars are red where the reading is lower than the quarter before.
mid-range by its own standards (47th percentile)
P/EMedianEPS (TTM) (quarterly)
38.8×₹94.629.6×₹71.020.4×₹47.311.2×₹23.72.0×₹0.0×11.80×₹88Mar 16Oct 18Jun 21Jan 24Jul 26
38.8×₹94.629.6×₹71.020.4×₹47.311.2×₹23.72.0×₹0.0×11.80×₹88Mar 16Jun 21Jul 26
PEG 0.25 PEG ratio per quarter — the P/E divided by the earnings-growth rate. The dashed line marks 1.0: below it the growth is cheap against the multiple, above it the price already prices the growth in. Last 20 quarters.
below 1.0, the growth looks cheap against the multiple
PEGPEG = 1.0
1.1×0.8×0.6×0.4×0.2××0.25×Q1 FY22Q1 FY23Q2 FY24Q3 FY25Q4 FY26
1.1×0.8×0.6×0.4×0.2××0.25×Q1 FY22Q2 FY24Q4 FY26
P/E
11.8×
47th percentile of 10y
PEG
n/m
not derivable — 3-year earnings growth unavailable

Why the multiple sits where it does: over the past year annual EPS moved +41.2% against a −24.8% price move — earnings outran the price, pushing the multiple DOWN its own range.

The price move, decomposed: over 5y, of the +2.2%/yr price move, ~+12.4%/yr came from earnings growth and ~−10.2 pp from the multiple (compressing); over 10y, of the +15.9%/yr price move, ~+15.3%/yr came from earnings growth and ~+0.6 pp from the multiple (roughly flat). The split is the honest approximate (price return minus earnings growth); it makes the rally itself visible instead of hiding it behind the percentile.

Put together: the multiple is unremarkable against its own past, so the story rests on the earnings line underneath it, not the multiple.

03 · Stage: Mixed

Stage: Mixed Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).

DCM Shriram Ltd reads as mixed on its fundamental arc. Mixed — no clean majority across the growth curves, ROCE holding at 11.7% — the per-curve reads carry the story. The read is built from 12 quarters across 4 curves, on full evidence.

Growth, year by year: revenue +12.1% in FY26, profit +41.7% Year-over-year growth per fiscal year, %: revenue (left axis); net profit and EPS (right axis — profit growth swings far wider). Zero line drawn.
Revenue YoYProfit YoYEPS YoY
22%94%15%55%7.3%16%0.0%−23%−7.4%−62%%%12.1%41.7%FY16FY21FY26
22%94%15%55%7.3%16%0.0%−23%−7.4%−62%%%12.1%41.7%FY16FY21FY26
Three growth curves, twelve quarters Year-on-year growth of trailing-twelve-month revenue (left axis), profit and EPS (right axis — they swing far wider), % at each quarter-end. A missing point means that reading is not held for the quarter.
the trajectory the stage is read from · revenue stabilising, profit accelerating
RevenueProfitEPS
16%147%9.9%93%4.3%39%−1.3%−15%−7.0%−69%%%11%132.4%132.1%Sep 23Dec 24Jun 26
16%147%9.9%93%4.3%39%−1.3%−15%−7.0%−69%%%11%132.4%132.1%Sep 23Dec 24Jun 26
ROCE Trailing-twelve-month operating profit (before interest and tax) as a share of average capital employed — total assets minus current liabilities, the standard textbook basis, %.
the return curve, computed quarterly
ROCE
14%12%11%10%9.0%%11.7%Sep 23Mar 24Dec 24Sep 25Jun 26
14%12%11%10%9.0%%11.7%Sep 23Dec 24Jun 26
Revenue growth
Flat
latest +11.0% · span −5.4% to +14.0%
Profit growth
Rising
latest +132.4% · span −54.1% to +132.4%
EPS growth
Rising
latest +132.1% · span −54.2% to +132.1%
ROCE
Stuck low
latest 11.7% · span 9.3%–13.3%

Why it matters: when the curves disagree, the per-curve reads above matter more than any single verdict.

The latest quarter’s profit carries a one-off item larger than the operating base, so the profit curve is shown but does not vote in the stage call.

Compound annual growth rate (%) Compound annual growth rate over each window, %. Revenue, profit and EPS from fiscal-year figures; share price is the price CAGR over the same spans. A dash = that window is not held, or the base was a loss.
1yr3yr5yr10yr
Revenue+12.1%+5.4%+10.3%+8.9%
Profit+41.7%−2.1%+4.9%+11.0%
EPS+41.2%−2.1%+4.9%+11.4%
Share price−24.8%+7.1%+2.2%+15.9%
Revenue YoY (Jun 26)
+9.3%
latest quarter vs a year ago
Profit YoY (Jun 26)
+507.9%
latest quarter vs a year ago
Revenue 10y
8.9%
long-run compound pace
04 · 4-Factor Sector Score

4-Factor Sector Score

60.5/100 — rank 2 of 20 in Sugar · 100% evidence confidence

DCM Shriram Ltd scores 60.5 out of 100 against the 20 companies it is compared with in Sugar, ranking 2. Acceleration candidate, not a confirmed leader: earnings are strong but sector-relative strength is -6.5% and the one-year return is -26%. Do not upgrade until sector-relative strength is above zero and another reported period confirms growth.

The four contributions add to the total exactly: 23.8 + 13 + 16.8 + 6.9 = 60.5. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.

What would change it: The read weakens if profit growth turns negative or margin improvement reverses while sector-relative strength deteriorates.

05 · Revenue

Revenue Revenue is the top line: everything the company billed its customers in the period.

DCM Shriram Ltd reported ₹3,564 Cr of revenue in the Jun 26 quarter, +9.3% year on year. That is the 9th straight quarter of year-on-year growth. Over 10 years it has compounded at 8.9% a year. The last full year, FY26, came in at ₹13,538 Cr. The last four reported quarters add to ₹13,840 Cr.

FY26 revenue came in at ₹13,538 Cr (+12.1% on the year), capping 10 years at 8.9% compound. The latest quarter (Jun 26) printed ₹3,564 Cr, +9.3% year on year — the 9th consecutive quarter of year-over-year growth.

FY26 revenue ₹13,538 Cr (+12.1% YoY) Revenue bars, ₹ Cr (left); YoY growth-% line (right). 11-year window. A bar is red when it is lower than the year before.
8.9% a year over 10 years
RevenueYoY growth
14.6k22%11.0k15%7.3k7.3%3.7k0.0%0−7.4%₹ Cr%₹13,53812.1%FY16FY21FY26
14.6k22%11.0k15%7.3k7.3%3.7k0.0%0−7.4%₹ Cr%₹13,53812.1%FY16FY21FY26
Jun 26: ₹3,564 Cr (+9.3% YoY) Quarterly revenue bars, ₹ Cr (left); YoY growth-% line (right). Last 12 quarters. A bar is red when it is lower than the quarter before.
9th straight quarter of growth
Revenue (quarterly)YoY growth
4.1k22%3.1k13%2.1k4.1%1.0k−5.1%0−14%₹ Cr%₹3,5649.3%Sep 23Dec 24Jun 26
4.1k22%3.1k13%2.1k4.1%1.0k−5.1%0−14%₹ Cr%₹3,5649.3%Sep 23Dec 24Jun 26

Pace check: the last four quarters averaged +11.1% growth against the decade's 8.9% — the current year is running faster than its own long-run rate.

Acceleration check: trailing-twelve-month revenue grew +11.0% over the last 4 quarters against +12.1%/yr over the last 8 — stabilising; TTM profit +132.4% vs +71.2%/yr — accelerating.

06 · Operating margin

Operating margin Operating margin is what is left of every ₹100 of sales after running the business, before interest and tax. It is the cleanest read on pricing power and cost control.

DCM Shriram Ltd's operating margin is 9.0% in the Jun 26 quarter, +0.0 percentage points against the same quarter a year ago. Across 13 fiscal years the operating margin has ranged 7.0% to 19.0%. The current quarter sits inside that band.

The latest quarter's operating margin is 9.0%, +0.0 pp against the same quarter a year ago. Across 13 fiscal years the operating margin has ranged 7.0%–19.0%.

Why the margin moved: operating margin went +0.1 pp year on year while gross margin went −0.7 pp — the gain came mostly from the gross line: input costs and pricing.

FY26: 11.0% Operating margin by fiscal year, %, line (left); year-on-year change in the margin, in percentage points, line (right). 13-year window.
within a 7.0–19.0% band over 13 years
operating marginYoY change (pp)
20%5.8%16%2.9%13%0.0%9.5%−2.9%6.0%−5.8%%%11%0%FY14FY20FY26
20%5.8%16%2.9%13%0.0%9.5%−2.9%6.0%−5.8%%%11%0%FY14FY20FY26
Jun 26: 9.0% operating margin (+0.0 pp YoY) Quarterly operating margin, %, line (left); year-on-year change in the margin, in percentage points, line (right). Last 12 quarters. Operating profit as a share of revenue, per quarter.
Operating marginYoY change (pp)
16%3.5%13%1.7%9.6%0.0%6.5%−1.7%3.3%−3.5%%%9%0%Sep 23Dec 24Jun 26
16%3.5%13%1.7%9.6%0.0%6.5%−1.7%3.3%−3.5%%%9%0%Sep 23Dec 24Jun 26
07 · Net profit

Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.

DCM Shriram Ltd earned ₹693 Cr of net profit in the Jun 26 quarter, +507.9% year on year. It is the 2nd consecutive quarter of growth. Full-year FY26 profit was ₹856 Cr. The 10-year compound rate is 11.0%. That is 19.4% of the quarter's revenue. The same quarter a year earlier earned ₹114 Cr.

Jun 26 profit was ₹693 Cr, +507.9% year on year — the 2nd consecutive quarter of growth. On the full year, FY26 printed ₹856 Cr (+41.7%), and the 10-year compound rate is 11.0%.

FY26 profit ₹856 Cr (+41.7% YoY) Net profit bars, ₹ Cr (left); YoY growth-% line (right). 11-year window. A bar is red when it is lower than the year before.
11.0% a year over 10 years
Net profitYoY growth
1.2k94%86455%57616%288−23%0−62%₹ Cr%₹85641.7%FY16FY21FY26
1.2k94%86455%57616%288−23%0−62%₹ Cr%₹85641.7%FY16FY21FY26
Jun 26: ₹693 Cr (+507.9% YoY) Quarterly net profit bars, ₹ Cr (left); YoY growth-% line (right). Last 12 quarters. A bar is red when it is lower than the quarter before.
2nd straight quarter of growth
Net profit (quarterly)YoY growth
748555%561385%374216%18747%0−122%₹ Cr%₹693507.9%Sep 23Dec 24Jun 26
748555%561385%374216%18747%0−122%₹ Cr%₹693507.9%Sep 23Dec 24Jun 26

Why profit moved: revenue contributed +9.3% and the margin +0.0 pp — the quarter was revenue-led, with the margin roughly flat.

Pace comparison, last four quarters: profit +187.2% vs revenue +11.1%. Profit is growing faster than sales — fixed costs are being spread over a bigger base, and each extra rupee of revenue drops more to the bottom line.

08 · Cash flow — the router

Cash flow — the router The P&L says what was earned; the cash-flow statement says what actually arrived. Operating cash flow (CFO) against profit is the cleanest lie detector in the accounts.

Over the last 3 fiscal years 165% of DCM Shriram Ltd's reported profit arrived as operating cash — the cash follows the profit. In FY26 that was ₹1,234 Cr of operating cash against ₹856 Cr of profit. After ₹1,240 Cr of capital spending, ₹−6.0 Cr was left as free cash.

FY26: operating cash of ₹1,234 Cr against reported profit of ₹856 Cr, leaving free cash of ₹−6.0 Cr after ₹1,240 Cr of capital spending. Across the last 3 fiscal years the conversion rate is 165% of profit.

Cash-flow readings here are annual — that is the resolution our series carries, so this section moves once a year.

FY26: CFO ₹1,234 Cr vs profit ₹856 Cr Operating cash flow and net profit by fiscal year, ₹ Cr; the line is free cash flow (CFO minus capital spending). 11-year window, annual resolution.
165% of 3-year profit arrived as cash
Operating cashNet profitFree cash
2.1k1.3k545−233−1.0k₹ Cr₹1,234₹856₹−6FY16FY21FY26
2.1k1.3k545−233−1.0k₹ Cr₹1,234₹856₹−6FY16FY21FY26
FY26: CFO = 144% of profit (three-year rate 165%) Operating cash as a share of net profit, per fiscal year, % (line). Dashed line = 100% — every unit of profit arriving as cash.
Conversion100%
300%228%157%85%13%%144%FY16FY21FY26
300%228%157%85%13%%144%FY16FY21FY26

Why conversion sits at 165%: the cash cycle stretched 17 days between FY21 and FY26 — more of each rupee of profit waits inside the cycle before arriving.

Router verdict: the bigger cash user is investment — capital spending ran 2.9× depreciation over three years, so the next section's job is to check what that build-out is buying.

09 · Where the cash goes

Where the cash goes Working capital is the cash tied up between paying suppliers and getting paid: debtor days (customers owe), inventory days (stock waits), and the cash conversion cycle (the whole loop, in days of sales).

DCM Shriram Ltd's cash conversion cycle runs 128 days in FY26, up from 111 days in FY21. Capital spending ran ₹3,569 Cr over the last 3 years. At FY26 sales of ₹13,538 Cr each day of that cycle holds about ₹37.1 Cr, so roughly ₹4,748 Cr sits inside the business at any moment.

FY26: debtors at 29 days, inventory at 162 days — roughly 5.3 months of stock waiting to sell; that is where the cash sits while it waits — for a full cycle of 128 days, looser than FY21's 111.

The full loop: cash goes out to suppliers and production on day 0; stock waits 162 days to sell; customers pay about 29 days after that; and suppliers themselves are paid at 64 days — netting out to the 128-day cycle.

In money terms: at FY26 sales of ₹13,538 Cr, each day of the cycle holds about ₹37.1 Cr — so the 128-day loop keeps roughly ₹4,748 Cr sitting inside the business at any moment.

FY26: a 128-day cash cycle Debtor days, inventory days, payable days and the cash conversion cycle by fiscal year. 13-year window.
+17 days vs FY21
Cash cycleInventory daysDebtor daysPayable days
223169115617days128d162d29d64dFY14FY17FY20FY23FY26
223169115617days128d162d29d64dFY14FY20FY26

On the investment side: capital spending of ₹3,569 Cr over the last 3 fiscal years against ₹1,215 Cr of depreciation — the company is building well ahead of wear-and-tear. Capital work-in-progress stands at ₹571 Cr (FY26) — capacity paid for but not yet earning.

FY26: capex ₹1,240 Cr, work-in-progress ₹571 Cr Capital spending per fiscal year, ₹ Cr (bars); capital work-in-progress, ₹ Cr (line). Quarterly capital-spending history is not held for India — annual is the honest resolution.
a build-out
CapexWork-in-progress
2.8k2.1k1.4k7060₹ Cr₹1,240₹571FY16FY18FY21FY23FY26
2.8k2.1k1.4k7060₹ Cr₹1,240₹571FY16FY21FY26

The synthesis: the cash is going into capacity, not disappearing into the cycle — the question becomes whether the new capacity earns.

10 · Return on capital

Return on capital Return on capital employed (ROCE) is the profit the whole business earns on all the money in it — equity and debt together. It is the single best test of whether growth creates value or just size.

DCM Shriram Ltd earns a ROCE of 12% in FY26. That is up from a trough of 9% in FY24. Return on invested capital clears the cost of that capital by −1.5 percentage points, so growth here is not yet paying for the capital it uses. The wiring behind it is 6.3% net margin on 0.96× asset turns.

FY26 ROCE is 12%, recovered from a FY24 trough of 9% — the full ladder below shows the fall and the climb, undoctored.

🚨 Why the return is what it is — the wiring (FY26): 6.3% net margin × 0.96× asset turns × 1.83× balance-sheet leverage ≈ 11.1% on equity. Margin does its share; leverage is a meaningful part of the equation.

The capstone test — ROIC − WACC: 10.5% − 12.0% = a −1.5 pp spread. The 12.0% is a standing assumption for the cost of capital in India, not a per-stock estimate — read the sign and the size of the spread, not the decimals. Negative — growth at these returns destroys value until the returns recover.

FY26: ROCE 12% Return on capital employed by fiscal year, % (line); ROIC by fiscal year, % (line). 13-year window, dips included. Dashed line = the 12.0% cost of capital used on this page.
the climb back from FY24's 9%
ROCEROIC (annual)WACC
31%24%17%11%4.1%%12%9.4%FY14FY20FY26
31%24%17%11%4.1%%12%9.4%FY14FY20FY26
Q4 FY26: ROCE 9.6% (TTM) vs WACC 12.0% Trailing-twelve-month ROCE and ROIC, per quarter, %; dashed line = the cost of capital. Last 12 quarters, put on a trailing-twelve-month basis and anchored to the annual figure.
ROCE (TTM)ROIC (TTM)WACC
15%13%11%8.5%6.2%%9.6%8.9%Q1 FY24Q2 FY25Q4 FY26
15%13%11%8.5%6.2%%9.6%8.9%Q1 FY24Q2 FY25Q4 FY26
11 · Debt

Debt Debt-to-equity says how much of the business is funded by borrowings. Low is the safe corner; the trend matters as much as the level.

DCM Shriram Ltd carries total debt of ₹2,923 Cr against shareholder equity of ₹7,733 Cr as of Mar 26, a debt-to-equity of 0.38. On the annual view that ratio went from 0.29 in FY22 to 0.38 in FY26. Read the returns elsewhere on this page with that leverage in mind.

Mar 26: total debt of ₹2,923 Cr against shareholder equity of ₹7,733 Cr — a debt-to-equity of 0.38. On the annual view, debt-to-equity went from 0.29 (FY22) to 0.38 (FY26). Read the returns on this page with that leverage in mind.

FY26: debt ₹2,923 Cr at 0.38× equity Total debt by fiscal year, ₹ Cr (bars); debt-to-equity, × (line). 5-year window.
Total debtDebt-to-equity
3.2k0.39×2.4k0.36×1.6k0.33×7890.30×00.27×₹ Cr×₹2,9230.38×FY22FY24FY26
3.2k0.39×2.4k0.36×1.6k0.33×7890.30×00.27×₹ Cr×₹2,9230.38×FY22FY24FY26
Mar 26: debt ₹2,923 Cr, debt-to-equity 0.38 Total debt per quarter, ₹ Cr (bars); debt-to-equity, × (line). Last 12 quarters. India reports the full balance sheet half-yearly, so the intervening quarter carries the prior reading forward.
Total debt (quarterly)Debt-to-equity
3.2k0.39×2.4k0.35×1.6k0.32×7890.28×00.24×₹ Cr×₹2,9230.38×Jun 23Sep 24Mar 26
3.2k0.39×2.4k0.35×1.6k0.32×7890.28×00.24×₹ Cr×₹2,9230.38×Jun 23Sep 24Mar 26
12 · Ownership

Ownership Who owns the stock, quarter by quarter: promoters (the controlling owners), foreign and domestic institutions, and the public. Steady accumulation by people close to the numbers is a signal; a quiet register is also an answer.

No holder of DCM Shriram Ltd moved a full percentage point over the last two years — the register is quiet. Foreign institutions moved +0.1 points over the same window, to 3.9%. The register is read on the four disclosed classes only; nothing is inferred between filings.

The register over the last two years — Domestic institutions: +0.4 points over 8 quarters to 8.4%; Foreign institutions: +0.1 points over 8 quarters to 3.9%; Promoters: +0.0 points over 8 quarters to 66.5%.

Fiscal-year ends: promoters +0.0 pts from Mar 24 to Mar 26 Shareholding at each fiscal-year end (March quarter), % of the company. 3 year-ends held.
PromotersForeign inst.Domestic inst.Public
72%53%35%17%−1.3%%66.5%4.0%8.6%20.2%Mar 24Mar 25Mar 26
72%53%35%17%−1.3%%66.5%4.0%8.6%20.2%Mar 24Mar 25Mar 26
A quiet register: no holder moved a full point in two years Shareholding by holder class, % of the company, quarterly, last 13 quarters.
PromotersForeign inst.Domestic inst.Public
72%53%35%16%−2.5%%66.5%3.9%8.4%20.4%Jun 23Dec 24Jun 26
72%53%35%16%−2.5%%66.5%3.9%8.4%20.4%Jun 23Dec 24Jun 26
13 · Safety line

Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.

DCM Shriram Ltd: the Z-score is not available for this stock, so we say so rather than invent one. It is a distance-to-distress estimate from the balance sheet, not a forecast of failure. The debt, cash-flow and return sections above carry the balance-sheet evidence this page does hold, and each of them states its own reporting date.

The safety line in one sentence: the Z-score is not available for this stock, so we say so rather than invent one.

14 · Related companies · Sugar
CompanyScorePrice stageGrowth & earnings/35Capital efficiency/25Valuation/20Relative strength/20
1Andhra Sugars LtdANDHRSUGAR 65.7/100Favorable setup83% evidence FADING 26.7/35 Revenue 22.1% · PAT 100% · OPM change -1.8 pp 83% evidence 12.9/25 ROCE 8.5% · OPM 7.5% 95% evidence 13.0/20 P/E 11.2× · PEG — 50% evidence 13.1/20 RS sector 8.6% · RS bench 1.9% · 1Y 2.2%6 of 12 weeks ahead 100% evidence
Exact sum: 26.7 + 12.9 + 13 + 13.1 = 65.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
2DCM Shriram Ltdthis pageDCMSHRIRAM 60.5/100Mixed-positive evidence100% evidence ASLEEP 23.8/35 Revenue 11.1% · PAT 100% · OPM change 0 pp 100% evidence 13.0/25 ROCE 11.5% · OPM 9% 100% evidence 16.8/20 P/E 11.8× · PEG 0.44 100% evidence 6.9/20 RS sector -6.5% · RS bench -12% · 1Y -26%0 of 12 weeks ahead 100% evidence
Exact sum: 23.8 + 13 + 16.8 + 6.9 = 60.5 · Decision use: Acceleration candidate, not a confirmed leader: earnings are strong but sector-relative strength is -6.5% and the one-year return is -26%. Do not upgrade until sector-relative strength is above zero and another reported period confirms growth.
3Uttam Sugar Mills LtdUTTAMSUGAR 58.4/100Mixed-positive evidence70% evidence ASLEEP 23.1/35 Revenue 19.2% · PAT 17.4% · OPM change 1 pp 83% evidence 17.1/25 ROCE 11.5% · OPM 21% 95% evidence 11.2/20 P/E 8.4× · PEG — 15% evidence 7.0/20 RS sector -9.1% · RS bench -8.2% · 1Y -17.3%5 of 10 weeks ahead 70% evidence
Exact sum: 23.1 + 17.1 + 11.2 + 7 = 58.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
4M.V.K. Agro Food Product LtdMVKAGRO 56.6/100Thin evidence · provisional52% evidence ASLEEP 18.2/35 Revenue — · PAT — · OPM change 17 pp 32% evidence 17.6/25 ROCE 14.4% · OPM 22% 95% evidence 8.8/20 P/E 35.8× · PEG — 15% evidence 12.0/20 RS sector 33.8% · RS bench -37.8% · 1Y 47.2%0 of 10 weeks ahead 70% evidence
Exact sum: 18.2 + 17.6 + 8.8 + 12 = 56.6 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
5Bannari Amman Sugars LtdBANARISUG 55.0/100Mixed-positive evidence96% evidence BASING 17.9/35 Revenue 6.9% · PAT 42.3% · OPM change -9.7 pp 88% evidence 14.9/25 ROCE 9.3% · OPM 1.3% 100% evidence 9.6/20 P/E 29.5× · PEG 1.75 100% evidence 12.6/20 RS sector 0.9% · RS bench -5% · 1Y -7.8%0 of 12 weeks ahead 100% evidence
Exact sum: 17.9 + 14.9 + 9.6 + 12.6 = 55 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
6Dalmia Bharat Sugar & Industries LtdDALMIASUG 54.2/100Mixed-positive evidence96% evidence ASLEEP 9.6/35 Revenue -3.2% · PAT -37.7% · OPM change -2 pp 88% evidence 13.1/25 ROCE 8.2% · OPM 17% 100% evidence 14.3/20 P/E 12.3× · PEG 0.48 100% evidence 17.2/20 RS sector 9.6% · RS bench 2.8% · 1Y -7.3%4 of 12 weeks ahead 100% evidence
Exact sum: 9.6 + 13.1 + 14.3 + 17.2 = 54.2 · Decision use: Price leads the evidence: RS versus the benchmark is 2.8%, but earnings trajectory is weak. Wait for revenue and profit confirmation.
7Dhampur Sugar Mills LtdDHAMPURSUG 52.4/100Mixed-positive evidence87% evidence ASLEEP 20.5/35 Revenue 1.3% · PAT 36.3% · OPM change 1.3 pp 95% evidence 8.5/25 ROCE 6.4% · OPM 5.7% 95% evidence 9.0/20 P/E 12.4× · PEG — 50% evidence 14.4/20 RS sector 7% · RS bench 0.4% · 1Y -6.8%5 of 12 weeks ahead 100% evidence
Exact sum: 20.5 + 8.5 + 9 + 14.4 = 52.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
8EID Parry (India) LtdEIDPARRY 50.9/100Mixed-positive evidence72% evidence ASLEEP 19.9/35 Revenue 21.9% · PAT -22.2% · OPM change 0 pp 83% evidence 16.9/25 ROCE 17% · OPM 8% 76% evidence 9.6/20 P/E 20.6× · PEG — 50% evidence 4.5/20 RS sector -20.5% · RS bench -18.4% · 1Y -35.3%0 of 10 weeks ahead 70% evidence
Exact sum: 19.9 + 16.9 + 9.6 + 4.5 = 50.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
9Balrampur Chini Mills LtdBALRAMCHIN 50.3/100Mixed-positive evidence96% evidence BREAKING OUT 15.3/35 Revenue 15.8% · PAT -13.1% · OPM change -6 pp 88% evidence 13.2/25 ROCE 9.3% · OPM 18% 100% evidence 2.4/20 P/E 32.7× · PEG 2.21 100% evidence 19.4/20 RS sector 24% · RS bench 16.5% · 1Y -0.5%8 of 12 weeks ahead 100% evidence
Exact sum: 15.3 + 13.2 + 2.4 + 19.4 = 50.3 · Decision use: Price leads the evidence: RS versus the benchmark is 16.5%, but earnings trajectory is weak. Wait for revenue and profit confirmation.
10Dhampur Bio Organics LtdDBOL 48.1/100Mixed-negative evidence72% evidence ASLEEP 21.0/35 Revenue 8% · PAT 100% · OPM change -0.1 pp 71% evidence 6.1/25 ROCE 5% · OPM 1.7% 95% evidence 9.7/20 P/E 25.4× · PEG — 15% evidence 11.3/20 RS sector 7.7% · RS bench 1% · 1Y 10.7%5 of 12 weeks ahead 100% evidence
Exact sum: 21 + 6.1 + 9.7 + 11.3 = 48.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
11Avadh Sugar & Energy LtdAVADHSUGAR 47.7/100Mixed-negative evidence83% evidence BREAKING OUT 8.9/35 Revenue 2.2% · PAT -34.8% · OPM change -4 pp 83% evidence 11.6/25 ROCE 6.8% · OPM 18% 95% evidence 8.1/20 P/E 16.1× · PEG — 50% evidence 19.1/20 RS sector 24.1% · RS bench 16.2% · 1Y 8.5%7 of 12 weeks ahead 100% evidence
Exact sum: 8.9 + 11.6 + 8.1 + 19.1 = 47.7 · Decision use: Price leads the evidence: RS versus the benchmark is 16.2%, but earnings trajectory is weak. Wait for revenue and profit confirmation.
12Bajaj Hindusthan Sugar LtdBAJAJHIND 47.6/100Mixed-negative evidence90% evidence ASLEEP 22.4/35 Revenue -2.2% · PAT 100% · OPM change 4 pp 88% evidence 9.4/25 ROCE 2.3% · OPM 22% 100% evidence 11.1/20 P/E 28.5× · PEG 1.32 100% evidence 4.7/20 RS sector -21% · RS bench -12.7% · 1Y -33.2%6 of 11 weeks ahead 70% evidence
Exact sum: 22.4 + 9.4 + 11.1 + 4.7 = 47.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
13Godavari Biorefineries LtdGODAVARIB 44.3/100Mixed-negative evidence76% evidence ASLEEP 20.1/35 Revenue 6.3% · PAT 100% · OPM change -4 pp 83% evidence 9.2/25 ROCE 6.5% · OPM 15% 95% evidence 8.7/20 P/E 39.7× · PEG — 15% evidence 6.3/20 RS sector -2.3% · RS bench -8.3% · 1Y -17.1%2 of 12 weeks ahead 100% evidence
Exact sum: 20.1 + 9.2 + 8.7 + 6.3 = 44.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
14Zuari Industries LtdZUARIIND 43.1/100Mixed-negative evidence62% evidence ASLEEP 18.8/35 Revenue 7.7% · PAT 100% · OPM change 1 pp 62% evidence 8.1/25 ROCE 5.5% · OPM 11% 95% evidence 11.5/20 P/E 6.6× · PEG — 15% evidence 4.7/20 RS sector -26.8% · RS bench -10.8% · 1Y -2.4%2 of 10 weeks ahead 70% evidence
Exact sum: 18.8 + 8.1 + 11.5 + 4.7 = 43.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
15Triveni Engineering and Industries LtdTRIVENI 36.7/100Mixed-negative evidence82% evidence ASLEEP 18.0/35 Revenue 4% · PAT 29.1% · OPM change 1 pp 95% evidence 9.6/25 ROCE 6.8% · OPM 3.4% 76% evidence 6.8/20 P/E 18.6× · PEG — 50% evidence 2.3/20 RS sector -33.2% · RS bench -3.8% · 1Y -39.6%0 of 12 weeks ahead 100% evidence
Exact sum: 18 + 9.6 + 6.8 + 2.3 = 36.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
16Davangere Sugar Company LtdDAVANGERE 36.3/100Mixed-negative evidence70% evidence 14.4/35 Revenue 11.1% · PAT -22.3% · OPM change -6.9 pp 83% evidence 8.9/25 ROCE 5.6% · OPM 10.1% 95% evidence 8.5/20 P/E 58.6× · PEG — 15% evidence 4.5/20 RS sector -25% · RS bench -12.6% · 1Y -47%1 of 8 weeks ahead 70% evidence
Exact sum: 14.4 + 8.9 + 8.5 + 4.5 = 36.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
17Magadh Sugar & Energy LtdMAGADSUGAR 36.0/100Mixed-negative evidence77% evidence ASLEEP 6.4/35 Revenue -5.9% · PAT -41.3% · OPM change -5 pp 83% evidence 11.9/25 ROCE 7.8% · OPM 27% 95% evidence 10.1/20 P/E 11.1× · PEG — 50% evidence 7.6/20 RS sector -19.1% · RS bench -0.8% · 1Y -11.1%2 of 10 weeks ahead 70% evidence
Exact sum: 6.4 + 11.9 + 10.1 + 7.6 = 36 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
18Dwarikesh Sugar Industries LtdDWARKESH 35.1/100Thin evidence · provisional54% evidence ASLEEP 16.7/35 Revenue 20.1% · PAT -80% · OPM change -8.2 pp 31% evidence 3.7/25 ROCE 5% · OPM -7.2% 80% evidence 9.5/20 P/E 25.6× · PEG — 15% evidence 5.2/20 RS sector -5.6% · RS bench -11.4% · 1Y -17.8%5 of 12 weeks ahead 100% evidence
Exact sum: 16.7 + 3.7 + 9.5 + 5.2 = 35.1 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
19Shree Renuka Sugars LtdRENUKA 17.1/100Adverse evidence76% evidence ASLEEP 2.4/35 Revenue -15.2% · PAT -80% · OPM change -9.5 pp 88% evidence 0.6/25 ROCE -3.1% · OPM 1.5% 100% evidence 10.0/20 P/E — · PEG — 0% evidence 4.1/20 RS sector -12.9% · RS bench -18.2% · 1Y -29.2%0 of 12 weeks ahead 100% evidence
Exact sum: 2.4 + 0.6 + 10 + 4.1 = 17.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
20DCM Shriram Industries LtdDCMSRIND 43.1/100Thin evidence · provisional48% evidence 12.3/35 Revenue -3.7% · PAT -50% · OPM change -6.8 pp 45% evidence 14.0/25 ROCE 13.7% · OPM 1.8% 71% evidence 8.8/20 P/E 8.2× · PEG — 50% evidence 8.0/20 RS sector — · RS bench -16.3% · 1Y — 25% evidence
Exact sum: 12.3 + 14 + 8.8 + 8 = 43.1 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.

Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led NIFTY 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.

15 · Frequently asked questions

Frequently asked questions

What is DCM Shriram Ltd's share price today?

DCM Shriram Ltd trades at ₹1,034, −24.8% over the past year. The company is valued at ₹16,123 Cr. The stock sits at 15% of its 52-week range of ₹990–₹1,281, −7.1% versus its 200-day average. On the tape, the price is in a downtrend, 8 weeks in. — as of 31 July 2026.

What were DCM Shriram Ltd's latest quarterly results?

DCM Shriram Ltd reported revenue of ₹3,564 Cr and net profit of ₹693 Cr for the Jun 26 quarter. Revenue rose 9.3% and profit rose 507.9% year on year. Earnings per share were ₹44.42. The operating margin was 9.0%, 0.0 pp higher than a year earlier. — as of 31 July 2026.

What is DCM Shriram Ltd's revenue?

DCM Shriram Ltd reported revenue of ₹3,564 Cr in the Jun 26 quarter, +9.3% year on year. For the full FY26 fiscal year, revenue was ₹13,538 Cr (+12.1%). Over the last 10 years revenue compounded at 8.9% a year. — as of 31 July 2026.

What is DCM Shriram Ltd's profit?

DCM Shriram Ltd earned ₹693 Cr of net profit in the Jun 26 quarter, +507.9% year on year — the 2nd straight quarter of growth. Full-year FY26 profit was ₹856 Cr. The operating margin ran 9.0% in the latest quarter. — as of 31 July 2026.

What is DCM Shriram Ltd's market cap?

DCM Shriram Ltd's market capitalisation is ₹16,123 Cr at a share price of ₹1,034. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 31 July 2026.

What is DCM Shriram Ltd's P/E ratio?

DCM Shriram Ltd trades at a P/E of 11.8×, at the 47th percentile of its own 10-year range, against a long-run median of 12.7×. This is a comparison with the stock's own history, not a value call — as of 31 July 2026.

Does DCM Shriram Ltd pay a dividend?

Yes — DCM Shriram Ltd's dividend payout was 21% of profit in FY26, and it recorded a payout in each of its last 13 reported fiscal years. This page holds the payout ratio, not a per-share amount. — as of 31 July 2026.

Is DCM Shriram Ltd overvalued?

On its own history, DCM Shriram Ltd looks mid-range against its own history: its P/E of 11.8× sits at the 47th percentile of its 10-year range (long-run median 12.7×). That is a percentile read against the stock's own past, not a price opinion or a direction call. — as of 31 July 2026.

Is DCM Shriram Ltd growing?

Yes — DCM Shriram Ltd is growing: latest-quarter revenue +9.3% year on year, profit +507.9%, and the margin +0.0 pp at 9.0%. The 10-year compound rates are 8.9% (revenue) and 11.0% (profit). The earnings engine currently reads: improving — as of 31 July 2026.

How is DCM Shriram Ltd performing?

DCM Shriram Ltd is in a downtrend, 8 weeks in. Its latest quarter's revenue rose 9.3% and profit rose 507.9% year on year. Against the NIFTY 500 it has been behind on a trailing-13-week view for 13 weeks. This describes what the data did, not a rating. — as of 31 July 2026.

What stage is DCM Shriram Ltd in?

Mixed — no clean majority across the growth curves, ROCE holding at 11.7% — the per-curve reads carry the story. The read comes from the last 12 quarters of growth (revenue growth +11.0% latest, profit growth +132.4% latest, eps growth +132.1% latest) plus the ROCE curve, classified by deterministic rules — a trajectory read, not a buy or sell call — as of 31 July 2026.

Is DCM Shriram Ltd in an uptrend?

No — the price is in a downtrend (week 8 of stage 4), trading −7.1% versus its 200-day average and at 15% of its 52-week range. Price stages cycle base → advance → top → decline, and the stage names where this stock sits in that cycle — as of 31 July 2026.

Is DCM Shriram Ltd beating the market?

Not lately — on a trailing-13-week view DCM Shriram Ltd is currently behind the NIFTY 500 (13 weeks and counting; last ahead the week of 2026-06-04), the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 10.4 years the stock moved +740% against the NIFTY 500's +276% — ahead of the index over the full window. — as of 31 July 2026.

Will DCM Shriram Ltd's share price go up?

This page publishes no price forecast for DCM Shriram Ltd. What it measures instead: the share price is ₹1,034, the price is in a downtrend 8 weeks in. Its P/E of 11.8× sits at the 47th percentile of its own 10-year range. — as of 31 July 2026.

Who owns DCM Shriram Ltd?

Promoters hold 66.5% of DCM Shriram Ltd, foreign institutions 3.9%, domestic institutions 8.4% and the public 20.4% (latest quarter). No holder moved a full point over the last two years — the register is quiet. — as of 31 July 2026.

Does DCM Shriram Ltd have too much debt?

It is moderate — DCM Shriram Ltd's debt-to-equity is 0.38, and operating profit covers the interest bill 9×. FY26 borrowings were ₹2,923 Cr against equity of ₹7,712 Cr. Read the returns on this page with that leverage in mind — as of 31 July 2026.

What is DCM Shriram Ltd's capex?

DCM Shriram Ltd spent ₹3,569 Cr on capital expenditure over the last 3 fiscal years, a figure derived from the change in fixed assets plus depreciation. In FY26 alone that was ₹1,240 Cr, with ₹571 Cr in capital work-in-progress — capacity paid for but not yet earning. — as of 31 July 2026.

What is DCM Shriram Ltd's cash flow?

DCM Shriram Ltd generated ₹1,234 Cr of operating cash flow in FY26 and ₹−6.0 Cr of free cash flow after ₹1,240 Cr of capital spending. Reported profit that year was ₹856 Cr, so operating cash ran ahead of profit. Cash-flow resolution for India is annual. — as of 31 July 2026.

Is DCM Shriram Ltd's profit real cash?

Yes — over the last 3 fiscal years, 165% of DCM Shriram Ltd's reported profit arrived as operating cash. In FY26, operating cash was ₹1,234 Cr against reported profit of ₹856 Cr. The cash then goes mostly into building capacity. Cash-flow resolution is annual — as of 31 July 2026.

Where is DCM Shriram Ltd in its business cycle?

DCM Shriram Ltd's FY26 operating margin was 11.0%, against a 13-year band of 7.0%–19.0%: mid-band by its own history — neither the peak that precedes mean-reversion nor the trough that precedes recovery. The latest quarter ran 9.0%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 31 July 2026.

What could break the DCM Shriram Ltd story?

The sharpest disagreement: annual EPS moved +41.2% against a −24.8% price move — the market has not yet caught up with the delivery. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 31 July 2026.

Is DCM Shriram Ltd a stock worth studying right now?

This is not investment advice. The machine read: DCM Shriram Ltd's earnings have outrun its stock. EPS grew +41.2% in a year against a −24.8% price move. The sharpest open question: whether the price catches up with earnings that have already moved. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 31 July 2026.

Chat with this pageChat with pageChatChatGPTClaudePerplexityGoogle AI